GraniteShares Launches Leveraged Single-Stock ETFs for ISRG and NBIS

GraniteShares has launched two new leveraged single-stock ETFs: GraniteShares 2x Long ISRG Daily ETF (ISUL) and GraniteShares 2x Long NBIS Daily ETF (NBIL). These funds offer daily leveraged exposure to Intuitive Surgical and Nebius Group stocks, respectively. Designed for short-term traders, they aim to provide 200% daily returns, before fees and expenses, corresponding to the percentage change of the respective underlying stocks. The ETFs are available on the NASDAQ exchange under the ticker symbols ISUL and NBIL.

GraniteShares has introduced two new leveraged single-stock ETFs: the GraniteShares 2x Long ISRG Daily ETF (ISUL) and the GraniteShares 2x Long NBIS Daily ETF (NBIL). These ETFs provide daily leveraged exposure to Intuitive Surgical, Inc. (ISRG) and Nebius Group (NBIS) stocks, respectively. Designed for short-term traders, they aim to offer 200% daily returns, before fees and expenses, corresponding to the percentage change of the respective underlying stocks. The ETFs are listed on the NASDAQ exchange under the ticker symbols ISUL and NBIL.

Intuitive Surgical, Inc., which closed at $452.35 on September 11, 2025, has seen a 2.11% increase from the previous day, outperforming the S&P 500's 0.01% gain Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing^[1]. Over the past month, ISRG shares have depreciated by 2.53%, underperforming the Medical sector's 4.67% gain and the S&P 500's 4.83% gain. The company is expected to post an EPS of $1.99 for the upcoming quarter, indicating an 8.15% growth compared to the same quarter last year. For the full year, the Zacks Consensus Estimates forecast earnings of $8.17 per share and revenue of $9.78 billion, reflecting changes of +11.31% and +17.06%, respectively, compared to the previous year Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing^[1].

Nebius Group (NBIS), on the other hand, has surged over 350% year-to-date in 2025, climbing from around $14 last October to roughly $128 by early October 2025 Nebius Group’s Meteoric Rise: $17B Microsoft AI Deal Propels Stock to New Highs – What’s Behind the Hype?^[2]. The company's stock performance has been driven by a 5-year, $17.4 billion AI infrastructure contract with Microsoft, which has significantly boosted its stock price. Nebius Group's Q2 2025 revenue was $105.1 million, up 625% year-over-year, while analysts project explosive growth ahead, with revenue hitting $4.25 billion by 2027 Nebius Group’s Meteoric Rise: $17B Microsoft AI Deal Propels Stock to New Highs – What’s Behind the Hype?^[2].

These new ETFs offer investors the opportunity to gain leveraged exposure to the stocks of these high-growth companies. However, it is important to note that leveraged ETFs involve higher risk and are generally not suitable for long-term investment. They are designed for short-term traders who can tolerate significant volatility and are comfortable with the potential for rapid gains or losses.